Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
HIV-1 Infection
Cancer
Immunosuppression
Interventions
OTHER:
serologic testing
Sponsor
Goethe University
Collaborators
[object Object]